Equity · Healthcare
MDXG
NASDAQMiMedx Group (MDXG)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Market cap
- 628.9M USD
- Revenue, year to Dec 2025
- 418.6M USD
- EPS, diluted, year to Dec 2025
- 0.32 USD
- 52-week range
- 3.09 USD – 7.95 USD
- Avg volume
- 357.1K
as of Jul 17, 2026
Have MiMedx Group (MDXG) insiders bought or sold shares recently?
MDXG's newest Form 4 filing is dated 2 July 2026: none in the last 90 days.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 06 Nov 2025 | Maersk-Moller KimberlyChief Commercial Officer | Sell | 58,300 | 432K USD |
21 other filings: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 02 Jul 2026 | DOUG RICEChief Financial Officer | Tax withheld | 12,749 | 50K USD |
| 24 Jun 2026 | Maersk-Moller KimberlyChief Commercial Officer | Tax withheld | 19,820 | 76K USD |
| 10 Jun 2026 | BIERMAN JAMES LDirector | Award | 50,913 | 185K USD |
| 10 Jun 2026 | HAWKINS WILLIAM ADirector | Award | 50,913 | 185K USD |
| 10 Jun 2026 | Olson TiffanyDirector | Award | 50,913 | 185K USD |
| 10 Jun 2026 | Newton ToddDirector | Award | 50,913 | 185K USD |
| 10 Jun 2026 | PUHY DOROTHY EDirector | Award | 50,913 | 185K USD |
| 13 Mar 2026 | Hulse William Frank IVGeneral Counsel and CAO | Tax withheld | 20,245 | 89K USD |
| 13 Mar 2026 | Maersk-Moller KimberlyChief Commercial Officer | Tax withheld | 6,762 | 30K USD |
| 10 Mar 2026 | DOUG RICEChief Financial Officer | Option exercise | 243,000 | 1.1M USD |
| 10 Mar 2026 | DOUG RICEChief Financial Officer | Tax withheld | 96,363 | 434K USD |
| 10 Mar 2026 | Hulse William Frank IVGeneral Counsel and CAO | Option exercise | 136,364 | 614K USD |
Showing the 12 most recent of 21 compensation filings in this window. The figures above count all of them.
Which funds hold MiMedx Group (MDXG)?
0 of the 45 institutional funds we track reported a MiMedx Group position for the quarter ended 30 Sep 2026; the latest of those filings landed 06 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Exited |
What has been filed or recorded for MiMedx Group (MDXG)?
The filings we hold for MiMedx Group, newest first: 3 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,497 shares | 7K USD notional · 0.001% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,459 shares | 7K USD notional · 0.001% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 3,700 shares | 17K USD notional · 0.003% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.06 USD | Revenue $62M |
| 30 Sep 2026 | Financials | Total assets | 264.6M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 211.1M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.10 USD | Revenue $64M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.07 USD | Revenue $59M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 0.32 USD | Revenue $419M |
| 31 Dec 2025 | Financials | Revenue | 418.6M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 48.6M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 0.32 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.11 USD | Revenue $114M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.06 USD | Revenue $99M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.05 USD | Revenue $88M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 0.28 USD | Revenue $349M |
What do people ask about MiMedx Group (MDXG)?
What is MiMedx Group’s market cap?628.9M
MiMedx Group is worth 628.9M USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.
What is MiMedx Group’s revenue?418.6M
MiMedx Group reported revenue of 418.6M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have MiMedx Group insiders bought or sold shares recently?
No MiMedx Group insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 2 Jul 2026 (SEC Form 4). See Insiders
Which funds own MiMedx Group?0 of 45
0 of the 45 funds we track reported a MiMedx Group position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds
When did MiMedx Group last report earnings?−0.06
MiMedx Group last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.06 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings